Back to School: Time For COVID-19 Vaccinations
It’s back-to-school time in much of the United States. In addition to purchasing school supplies, parents are also scheduling physicals,…
It’s back-to-school time in much of the United States. In addition to purchasing school supplies, parents are also scheduling physicals,…
In-person medical conferences are back in full swing this year, and members of the oncology community are weighing the risks…
Patients with advanced chronic kidney disease (CKD) have increased risks for hospitalization and death after COVID-19 infection. Yet PaxlovidTM (nirmatrelvir…
A lack of mask mandates at cancer centers and elsewhere has left cancer patients feeling unsafe and abandoned by society.…
State-licensed pharmacists can now prescribe Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets) with certain limitations to eligible patients, according to…
Following a unanimous vote of support by the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee,…
Following a unanimous vote of support by the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee,…
Good news for people with food allergies — having a food allergy cuts your risk of being infected with COVID-19…
The Food and Drug Administration (FDA)’s Vaccines and Related Biological Products Advisory Committee voted 21 to 0 (with 1 abstention)…
Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets) continues to be recommended for early stage treatment of mild to moderate COVID-19…